Excess Mortality and Morbidity in Patients with Craniopharyngioma, Especially in Patients with Childhood Onset: A Population-Based Study in Sweden
- 1 February 2015
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 100 (2) , 467-474
Abstract
Context: Craniopharyngiomas (CPs) in adults have been associated with excess mortality.Objective: The aim of the study was to investigate mortality and morbidity in patients with childhood-onset and adult-onset CP.Methods: Patients with CP were identified and followed in Swedish national health registries, 1987 through 2011. The inclusion criteria for the CP diagnosis were internally validated against patient records in 28% of the study population.Settings: This was a nationwide population-based study.Patients: A total of 307 patients (151 men and 156 women) were identified and included (mean follow-up, 9 years; range, 0–25 years). The inclusion criteria had a positive predictive value of 97% and a sensitivity of 92%.Intervention: There were no interventions.Main Outcome Measures: Standardized mortality ratios (SMRs) and standardized incidence ratios (SIRs) with 95% confidence intervals were calculated using the Swedish population as the reference.Results: During the study, 54 patients died compared with the expected number of 14.1, resulting in an SMR of 3.2 (2.2–4.7) for men and 4.9 (3.2–7.2) for women. Patients with childhood-onset (n = 106) and adult-onset (n = 201) CP had SMRs of 17 (6.3–37) and 3.5 (2.6–4.6), respectively. Patients with hypopituitarism (n = 250), diabetes insipidus (n = 110), and neither of these (n = 54) had SMRs of 4.3 (3.1–5.8), 6.1 (3.5–9.7), and 2.7 (1.4–4.6), respectively. The SMR due to cerebrovascular diseases was 5.1 (1.7–12). SIRs were 5.6 (3.8–8.0) for type 2 diabetes mellitus, 7.1 (5.0–9.9) for cerebral infarction, 0.7 (0.2–1.7) for myocardial infarction, 2.1 (1.4–3.0) for fracture, and 5.9 (3.4–9.4) for severe infection. The SIR for all malignant tumors was 1.3 (0.8–2.1).Conclusions: This first nationwide population-based study of patients with CP demonstrated excess mortality that was especially marked in patients with childhood-onset disease and among women. Death due to cerebrovascular diseases was increased 5-fold. Hypopituitarism and diabetes insipidus were negative prognostic factors for mortality and morbidity. Patients with CP had increased disease burden related to type 2 diabetes mellitus, cerebral infarction, fracture, and severe infection.Keywords
This publication has 26 references indexed in Scilit:
- Mortality and morbidity in adult craniopharyngiomaPituitary, 2012
- Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-upEuropean Journal of Endocrinology, 2012
- Overall and cause-specific mortality in GH-deficient adults on GH replacementEuropean Journal of Endocrinology, 2012
- ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with AcromegalyThe Journal of Clinical Endocrinology & Metabolism, 2009
- Premature Mortality in Patients with Addison’s Disease: A Population-Based StudyThe Journal of Clinical Endocrinology & Metabolism, 2006
- CraniopharyngiomasEndocrine Reviews, 2006
- High prevalence of long‐term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngiomaClinical Endocrinology, 2004
- Association between premature mortality and hypopituitarismThe Lancet, 2001
- Epidemiological Study of Primary Intracranial Tumors in ChildhoodPediatric Neurosurgery, 1996
- Premature mortality due to cardiovascular disease in hypopituitarismThe Lancet, 1990